Brandi Martin
Family · Texarkana, TXNPI 1144872839
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $3,870 of the $5,411 with a category attached, or 71.5%. Amylyx Pharmaceuticals, Inc. accounts for 71.5% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2023 at $4,252 and has fallen 97.8% since, to $92 in 2025. Among family clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 49 payments — averaging $110.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amylyx Pharmaceuticals, Inc.$4K
- Johnson & Johnson$564
- W. L. Gore & Associates, Inc.$240
- Smith+Nephew$118
- Endologix LLC$95
- Amgen$85
- plus $438 from 11 others
What the payments were for
- Speaking & faculty fees$3,87072%
- Food & beverage$1,54128%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amylyx Pharmaceuticals, Inc. | 3 | $3,870 |
| Johnson & Johnson | 17 | $564 |
| W. L. Gore & Associates, Inc. | 2 | $240 |
| Smith+Nephew | 2 | $118 |
| Endologix LLC | 3 | $95 |
| Amgen(2 entities) | 5 | $85 |
| Angiodynamics, Inc. | 3 | $83 |
| Silk Road Medical, Inc. | 3 | $75 |
| Novo Nordisk | 1 | $69 |
| Mallinckrodt Hospital Products Inc. | 1 | $33 |
| KCI USA, Inc. | 2 | $32 |
| Travere Therapeutics, Inc. | 1 | $29 |
| Teleflex LLC | 2 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Millicent US Inc | 1 | $22 |
| Cardiovascular Systems Inc. | 1 | $22 |
| Terumo Medical Corporation | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,411 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $10,754 |
| ClopidogrelClopidogrel Bisulfate | 24 | $405 |
Paid to pharmacies, not to this prescriber.
Other family in Texarkana
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.